Form C - Offering Statement:
SEC Accession No. 0002017651-24-000001
Filing Date
2024-10-28
Accepted
2024-10-28 15:29:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 10395
2 offering_statement.pdf EX-99 571175
3 exhibit_a.pdf EX-99 385638
4 exhibit_b.pdf EX-99 1043801
5 exhibit_c.pdf EX-99 304296
6 exhibit_d.pdf EX-99 356302
7 exhibit_e.pdf EX-99 362006
  Complete submission text file 0002017651-24-000001.txt   4175263
Mailing Address 450 SINCLAIR ST RENO NV 89501
Business Address 450 SINCLAIR ST RENO NV 89501 415-246-3311
Sarcomatrix Therapeutics Corp (Filer) CIK: 0002017651 (see all company filings)

EIN.: 882525253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-34981 | Film No.: 241400470